High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.

As shown in Figs 2A and 3A , the 2D-PCA score plot present a clear trend of trajectories separation in three groups, and the Rg1-treated group trajectory is more close to control group, which reveals that the metabolic discrepancy have occured in control, model and Rg1-treated group, and Ginsenoside Rg1 facilitates model mice from disorder to normal state.

also in 19,460 other papers